Home based management in multiple sclerosis: results of a randomised controlled trial

Background: Home based medical care is a popular alternative to standard hospital care but there is uncertainty about its cost-effectiveness. Objectives: To compare the effectiveness and the costs of multidisciplinary home based care in multiple sclerosis with hospital care in a prospective randomised controlled trial with a one year follow up. Methods: 201 patients with clinically definite multiple sclerosis were studied. They were randomised in a ratio 2:1 to an intervention group (133) or a control group (68). They were assessed at baseline and one year after randomisation with validated measures of physical and psychological impairment and quality of life (SF-36 health survey). The costs to the National Health Service over the one year follow up were calculated by a cost minimisation analysis. Results: There were no differences in functional status between the home based care group and the hospital group. There was a significant difference between the two groups favouring home based management in four SF-36 health dimensions—general health, bodily pain, role-emotional, and social functioning (all p ≤ 0.001). The cost of home based care was slightly less (822 euros/patient/year) than hospital care, mainly as a result of a reduction in hospital admissions. Conclusions: Comprehensive planning of home based intervention implemented by an interdisciplinary team and designed specifically for people with multiple sclerosis may provide a cost-effective approach to management and improve the quality of life.

[1]  P. Narayana,et al.  Determinants of overall quality of life in secondary progressive MS: A longitudinal study , 2001, Neurology.

[2]  A. Thompson,et al.  Does adding MS-specific items to a generic measure (the SF-36) improve measurement? , 2001, Neurology.

[3]  R. Baxter.  Inhibition of the Insulin-Like Growth Factor (IGF)–IGF-Binding Protein Interaction , 2001, Hormone Research in Paediatrics.

[4]  B. Jönsson,et al.  Costs, quality of life and disease severity in multiple sclerosis: a cross‐sectional study in Sweden , 2001, European journal of neurology.

[5]  A J Thompson,et al.  Community services in multiple sclerosis: still a matter of chance , 2000, Journal of neurology, neurosurgery, and psychiatry.

[6]  C. Anderson,et al.  Home or hospital for stroke rehabilitation? results of a randomized controlled trial : I: health outcomes at 6 months. , 2000, Stroke.

[7]  B. Jönsson,et al.  Costs, Quality of Life and Disease Severity in Multiple Sclerosis - A Population-Based Cross- Sectional Study in Sweden , 2000 .

[8]  A. Thompson,et al.  Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[9]  D. Bates,et al.  Treatment of multiple sclerosis with interferon β: an appraisal of cost-effectiveness and quality of life , 2000 .

[10]  L. Gundersen.  There's no place like home: the home health care alternative. , 1999, Annals of internal medicine.

[11]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. , 1999, Brain : a journal of neurology.

[12]  Deborah M. Miller,et al.  Using the Short Form-36 with Multiple Sclerosis Patients in Five Countries: A Cross-Cultural Comparison , 1999, Psychological reports.

[13]  R. A’Hern,et al.  Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. , 1999, BMJ.

[14]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[15]  D. Mant,et al.  General practice Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina : final results of the Southampton heart integrated care project ( SHIP ) , 1999 .

[16]  M. Naylor,et al.  Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. , 1999, JAMA.

[17]  L Mendozzi,et al.  Physical rehabilitation has a positive effect on disability in multiple sclerosis patients , 1999, Neurology.

[18]  K Whetten-Goldstein,et al.  A comprehensive assessment of the cost of multiple sclerosis in the United States , 1998, Multiple sclerosis.

[19]  S Shepperd,et al.  The effectiveness of hospital at home compared with in-patient hospital care: a systematic review. , 1998, Journal of public health medicine.

[20]  P. O'Brien,et al.  Health care utilization in multiple sclerosis , 1998, Neurology.

[21]  R. Loos,et al.  Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium) , 1998, Journal of neurology, neurosurgery, and psychiatry.

[22]  A J Thompson,et al.  The impact of inpatient rehabilitation on progressive multiple sclerosis , 1997, Annals of neurology.

[23]  P. Dorman,et al.  Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis , 1997, BMJ.

[24]  J. Petajan,et al.  Impact of aerobic training on fitness and quality of life in multiple sclerosis , 1996, Annals of neurology.

[25]  L. Rubenstein,et al.  A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. , 1995, The New England journal of medicine.

[26]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[27]  F. Weaver,et al.  Cost-effectiveness of Veterans Administration hospital-based home care. A randomized clinical trial. , 1990, Archives of internal medicine.

[28]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[29]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[30]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[31]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[32]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[33]  T Tamata,et al.  HOME or hospital? , 1979, Lancet.

[34]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[35]  M. Myslinski.  Comparison of a Generic to Disease-Targeted Health-Related Quality-of-Life Measures for Multiple Sclerosis. , 2000 .

[36]  D. Bates,et al.  Treatment of multiple sclerosis with interferon β: an appraisal of cost-effectiveness and quality of life , 2000, Journal of neurology, neurosurgery, and psychiatry.

[37]  H. Karpatkin.  Quality of Life in Multiple Sclerosis: Measuring the Disease Effects More Broadly. , 2000 .

[38]  Alan J. Thompson,et al.  Multiple Sclerosis: Clinical Challenges and Controversies , 1997 .

[39]  A. Thompson,et al.  Assessing the quality of life of patients with multiple sclerosis , 1997 .

[40]  A. Petruckevitch,et al.  The Functional Independence Measure: a comparative validity and reliability study. , 1995, Disability and rehabilitation.

[41]  John E. Ware,et al.  SF-36 physical and mental health summary scales : a user's manual , 1994 .

[42]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[43]  R. Cattell,et al.  Handbook for the IPAT anxiety scale questionnaire : self analysis form , 1963 .

[44]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.